NIH-funded vaccine for West Nile Virus enters human clinical trials

(NIH/National Institute of Allergy and Infectious Diseases) A clinical trial of a new investigational vaccine designed to protect against West Nile Virus infection will be sponsored by the NIAID. The experimental vaccine was discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health & Science University in Portland. The scientists were funded with a $7.2 million grant from NIAID, awarded in 2009. The new vaccine is being tested in a Phase 1 clinical tr...